Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dunne

Showing results (461-470 of 473) with videos related to

Pageof 48
Sort By:
Proceedings. Biological Sciences|March 12, 2024
Academic publishing requires linguistically inclusive policiesHenry Arenas-Castro, Violeta Berdejo-Espinola, Shawan Chowdhury, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
Science (New York, N.Y.)|May 17, 2014
Oxidation products of biogenic emissions contribute to nucleation of atmospheric particlesFrancesco Riccobono, Siegfried Schobesberger, Catherine E Scott, et al.
Emerging Infectious Diseases|October 19, 2020
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture WorkplacesMichelle A Waltenburg, Charles E Rose, Tristan Victoroff, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
Science (New York, N.Y.)|November 3, 2016
Global atmospheric particle formation from CERN CLOUD measurementsEimear M Dunne, Hamish Gordon, Andreas Kürten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2021
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
Pageof 48

Showing results (461-470 of 473) with videos related to

Sort By:
Pageof 48
Proceedings. Biological Sciences|March 12, 2024
Academic publishing requires linguistically inclusive policiesHenry Arenas-Castro, Violeta Berdejo-Espinola, Shawan Chowdhury, et al.
MMWR. Morbidity and Mortality Weekly Report|July 21, 2022
Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated - VISION Network, 10 States, December 2021-June 2022Ruth Link-Gelles, Matthew E Levy, Manjusha Gaglani, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022Mark G Thompson, Karthik Natarajan, Stephanie A Irving, et al.
JAMA Network Open|March 15, 2023
Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage PeriodsRuth Link-Gelles, Matthew E Levy, Karthik Natarajan, et al.
Science (New York, N.Y.)|May 17, 2014
Oxidation products of biogenic emissions contribute to nucleation of atmospheric particlesFrancesco Riccobono, Siegfried Schobesberger, Catherine E Scott, et al.
Emerging Infectious Diseases|October 19, 2020
Coronavirus Disease among Workers in Food Processing, Food Manufacturing, and Agriculture WorkplacesMichelle A Waltenburg, Charles E Rose, Tristan Victoroff, et al.
MMWR. Morbidity and Mortality Weekly Report|March 31, 2022
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022Karthik Natarajan, Namrata Prasad, Kristin Dascomb, et al.
Science (New York, N.Y.)|November 3, 2016
Global atmospheric particle formation from CERN CLOUD measurementsEimear M Dunne, Hamish Gordon, Andreas Kürten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 30, 2021
Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
MMWR. Morbidity and Mortality Weekly Report|November 4, 2021
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021Peter J Embi, Matthew E Levy, Allison L Naleway, et al.
Pageof 48